Results 81 to 90 of about 4,992,809 (126)

Dermatoscopic features of blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia
Blastic plasmacytoid dendritic cell neoplasm is a malignant, aggressive, and rare tumor arising from plasmacytoid dendritic cell precursors. Because of its infrequency, information on clinical features and best treatment options is still lacking ...
Daniel Argüello-Ruiz   +2 more
doaj  

Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous involvement in a 25 years male patient: Unusual presentation of a rare entity

open access: yesIndian Journal of Pathology and Microbiology, 2015
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive neoplasm classified under "acute myeloid leukemia (AML) and related precursor neoplasm" by current WHO classification.
Sumaira Qayoom   +3 more
doaj   +1 more source

Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations. [PDF]

open access: yes
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare malignancy derived from plasmacytoid dendritic cells, can mimic both acute leukemia and aggressive T-cell lymphoma.
Pollak, Matthias   +22 more
core   +2 more sources

Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases

open access: yesHaematologica, 2006
CD4+/CD56+ hematodermic neoplasm (WHO-EORTC) or blastic NK-cell lymphoma (WHO) is a rare aggressive (CD4+)(CD56+)lin- skin-tropic lymphoma of putative early-plasmacytoid dendritic cell origin.
AP Ng   +5 more
doaj  

Blastic plasmacytoid dendritic cell neoplasm mimicking dermatomyositis

open access: yesJAAD Case Reports, 2023
Christopher J. Fay, BA   +4 more
doaj   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm Expressing the CD13 Myeloid Antigen

open access: yes, 2011
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), currently considered to originate from immature plasmacytoid dendritic cells (DC), is a rare and aggressive CD4+CD56+ neoplasm that frequently involves the skin and bone marrow.
Takayuki Takahashi   +8 more
core   +1 more source

Pseudo-Rosette-Forming Blastic Plasmacytoid Dendritic Cell Neoplasm

open access: yesTurkish Journal of Hematology, 2020
Praveen Sharma, Shano Naseem
doaj   +1 more source

Blastic plasmacytoid dendritic neoplasm / Nabia Idaam Mustapa Albakari [PDF]

open access: yes, 2018
Blastic plasmacytoid dendritic neoplasm (BPCDN) is a rare entity and difficult to diagnose. It is highly aggressive with a poor diagnosis. Early diagnosis may help with treatment.
Mustapa Albakari, Nabia Idaam
core  

Concomitant Occurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm and Acute Myeloid Leukaemia after Lenalidomide Treatment for del(5q) Myelodysplastic Syndrome

open access: yes, 2017
Background: Myelodysplastic syndromes with chromosome 5 long arm deletion (5q-MDS) may benefit from lenalidomide treatment. However, unresponsive patients have a high risk for clonal evolution and progression to acute myeloid leukemia.
A. Freyrie   +13 more
core   +1 more source

Blastic plasmacytoid dendritic cell neoplasm: case series and a brief review of literature

open access: yes, 2016
Blastic plasmacytoid dendritic cell neoplasm is a very aggressive disease wich has been classified by the World Health Organization among “acute myeloid leukemia and related precursor neoplasms” in 2008.
DI MEO, NICOLA   +5 more
core  

Home - About - Disclaimer - Privacy